KRAS and colonic neoplasm: In the azoxymethane mouse model of colorectal carcinogenesis, administration of DCA significantly increased K-ras mutations and the incidence of colonic tumours (71), whilst UDCA was shown to suppress the development of colorectal cancers with K-ras mutations (72).